Anbio Biotechnology (NNNN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Anbio Biotechnology reported total assets of $30.24M and total liabilities of $87.84K. Shareholders' equity was $30.16M, up 75.4% from $17.19M a year earlier. Total debt stood at $0.00 against $11.90M in cash and short-term investments, a net cash position of $11.90M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Anbio Biotechnology Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Anbio Biotechnology (NNNN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	7.77	11.76	9.69	7.10	4.18
Short-Term Investments	4.13	0.00	0.00	1.57	0.00
Cash & Short-Term Investments	11.90	11.76	9.69	8.67	4.18
Accounts Receivable	3.66	1.06	1.88	0.00	0.72
Inventory	0.00	0.00	0.00	0.35	0.00
Other Current Assets	14.68	5.71	4.18	4.92	0.02
Total Current Assets	30.24	18.53	15.75	13.94	4.92
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.01	0.00
Other Non-Current Assets	0.00	0.39	0.06	0.00	0.00
Total Non-Current Assets	0.00	0.39	0.06	0.02	0.00
Total Assets	30.24	18.92	15.81	13.96	4.92
Current Liabilities
Accounts Payable	0.00	1.63	0.83	1.41	1.89
Accrued Liabilities	-	-	0.13	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.49
Other Current Liabilities	0.09	0.10	0.17	0.00	0.49
Total Current Liabilities	0.09	1.73	0.99	1.41	2.38
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Liabilities	0.09	1.73	0.99	1.41	2.38
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.00
Retained Earnings	23.58	17.17	14.80	12.55	2.54
Additional Paid-in Capital	6.56	0.00	0.00	0.00	0.00
Shares Outstanding	43.89	43.89	43.89	43.89	43.89
Total Stockholders' Equity	30.16	17.19	14.82	12.55	2.54
Total Liabilities & Equity	30.24	18.92	15.81	13.96	4.92

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Anbio Biotechnology Balance Sheet

How much debt does Anbio Biotechnology have?

Anbio Biotechnology had total debt of $0.00 as of Dec 31, 2025, against $11.90M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Anbio Biotechnology's total assets?

Anbio Biotechnology reported total assets of $30.24M as of Dec 31, 2025, up 59.8% from $18.92M a year earlier. Total liabilities were $87.84K.

What is Anbio Biotechnology's shareholders' equity?

Anbio Biotechnology's shareholders' equity was $30.16M as of Dec 31, 2025, or about $0.69 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition